Jynarque 90MG/30MG
Ended Awarded
- Contract number
- 36C24524N0330
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,560
Award facts
- Contract value 100% obligated
- $12,559.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. was awarded a $12,559.90 firm fixed price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 5 on February 14, 2024, with an ultimate completion date of February 16, 2024. The contract covers the supply of Jynarque 90mg/30mg, a specialty pharmaceutical product used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. The delivery order was issued without a set-aside designation and is performed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with the place of performance in Pittsburgh, Pennsylvania.
This delivery order is executed under Otsuka America Pharmaceutical Inc.'s larger Blanket Purchase Agreement with the VA's National Acquisition Center, which carries a total value of approximately $83.3 million and extends through March 26, 2026. The BPA enables VA facilities across multiple Integrated Service Networks to efficiently procure Jynarque in various dosages. Otsuka America Pharmaceutical Inc., headquartered in Rockville, Maryland, is an established federal contractor with a robust $396 million Federal Supply Schedule contract for pharmaceuticals and related products, positioning it as a key supplier of specialized medications to the VA's Veterans Health Administration across the nation.
Quick answers
Who was awarded contract 36C24524N0330?
36C24524N0330 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 14, 2024.
How much is contract 36C24524N0330 worth?
The government has obligated $12,560 on 36C24524N0330.
Is contract 36C24524N0330 an order under another contract?
Yes. 36C24524N0330 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0330 competed?
The extent of competition for 36C24524N0330 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award